Prof. Tami Livnat is the new head of the TAU Amalia Biron Research Institute of Thrombosis and Hemostasis
Prof. Livnat is an Associate Professor in the Department of Hematology at the Faculty of Medicine, and serves as Head of the Basic Research Laboratory, the National Hemophilia Center, Thrombosis Institute of the Sheba Medical Center. She completed her Ph.D. studies at Bar-Ilan University and conducted postdoctoral training at Tel Aviv University. Throughout her career, she has been driven by a deep-rooted passion for advancing research in thrombosis and hemostasis, with the ultimate goal of enhancing patient care.
Prof. Livnat’s research encompasses two complementary facets of coagulation factor activities. Firstly, she has focused on investigating plasma-related activities to develop comprehensive laboratory assays for assessing the coagulation status of patients. This includes diagnosing rare bleeding disorders, evaluating novel therapeutic interventions, and exploring anticoagulant systems. In parallel, she explored the cellular signaling activities induced by coagulation factors. She has been particularly fascinated by the multi-target, multi-action cytoprotective activities of the natural anticoagulant, activated protein C (APC). To advance this inquiry, Prof. Livnat established a collaborative research group with the Institute of Thrombosis & Hemostasis at Sheba Medical Center, the Ophthalmology Division at Rabin Medical Center, and the Laboratory of Eye Research at the Felsenstein Research Center. The groups’ collective efforts are dedicated to developing innovative therapeutic approaches based on APC and its analogs for neurodegenerative ocular pathologies, ultimately preserving patients' vision.
The essence of Prof. Livnat’s work revolves around teamwork, bringing together dedicated researchers and physicians, and is funded by competitive basic science and industry-driven grants. This aspiration perfectly aligns with the unique nature of the Amalia Biron Research Institute of Thrombosis and Hemostasis, which bridges basic and clinical research. Prof. Livnat have been actively engaged with this institution since its establishment.